Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus

Yuhei Tanaka1, Kenji Gotoh1, Mariko Teramachi1

  • 1Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.

Insights

Macrolide resistance in Streptococcus pyogenes (GAS) is common in Japanese children, with over 40% of isolates resistant. The mefA gene was the most frequent resistance mechanism identified in these macrolide-resistant GAS strains.

Area of Science:

  • Microbiology
  • Epidemiology
  • Molecular Biology

Background:

  • Streptococcus pyogenes (group A streptococci, GAS) causes pharyngotonsillitis in children.
  • Macrolide resistance in GAS is a growing public health concern.
  • Understanding the molecular epidemiology of resistant strains is crucial for effective treatment.

Purpose of the Study:

  • To investigate the molecular epidemiology of macrolide-resistant GAS in children with pharyngotonsillitis in Japan.
  • To characterize the genetic basis and prevalence of macrolide resistance mechanisms.
  • To identify dominant GAS strains and their resistance profiles.

Main Methods:

  • Isolation and characterization of 299 GAS isolates from children with pharyngotonsillitis (2011-2013).
  • Molecular typing including emm typing, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE).
  • Detection of macrolide resistance genes (mefA, ermB, msrD, ermTR).

Main Results:

  • 124 out of 299 (41.5%) GAS isolates were macrolide-resistant.
  • The mefA gene (with msrD) was present in 76 isolates (M phenotype), and ermB was present in 46 isolates (cMLSB phenotype).
  • emm1/ST28 (M phenotype) and emm12/ST467 (cMLSB phenotype) were the predominant types, with high proportions of macrolide-resistant GAS found in southwestern Japan.

Conclusions:

  • Macrolide resistance is highly prevalent in pediatric GAS isolates in Japan.
  • The mefA/msrD complex and ermB are the primary genetic determinants of macrolide resistance.
  • Geographical variations in resistance and specific emm/MLST types highlight the need for ongoing surveillance.